The effect of dexmedetomidine in the acute decompensated heart failure

Phase 4

• Conditions: heart failure

• Registration Number: JPRN-UMIN000012323
• Lead Sponsor: Higashiosaka City General Hospital cardiovascular medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-20
• Study Completion: 2015-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

Under systoric blood pressure 80 mmHg

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rine output,Catecholamine fraction(dopamine,adrenalin,noradrenalin),Renin activaion,aldosterone,ADH before and after the use od Dexmedetomidine in ADHF Survival rate of one,three,five years

Secondary Outcome Measures

Name	Time	Method
Creatinine,Heart rate,Blood pressure,Interleukin6,TNF-6,blood serum and urine Na K Cl,blood and urine osmotic pressure